Literature DB >> 1696486

The solitary schwannoma of the eighth cranial nerve. An immunohistochemical study of the cochlear nerve-tumor interface.

J F Marquet1, G E Forton, F E Offeciers, L L Moeneclaey.   

Abstract

Given recent controversy concerning hearing preservation surgery of the acoustic neurinoma, an immunohistochemical study was undertaken to investigate the cochlear nerve-tumor interface. Ten intact medium-sized acoustic neurinomas were studied by means of classic staining procedures and an immunohistochemical technique using monoclonal mouse antibodies to human neurofilaments. Our observations indicate that the cochlear nerve is histologically involved in the tumoral process in those cases in which macroscopically visible adherences between the cochlear nerve and the tumor are present. We were not able to discern a clear cleavage plane. Six of the 10 specimens showed tumoral invasion of the cochlear nerve. Several therapeutic attitudes are discussed in view of these observations and reports from the international literature. In conclusion, the principle of hearing preservation surgery is rejected in favor of total tumor removal in every case in which surgery is indicated.

Entities:  

Mesh:

Year:  1990        PMID: 1696486     DOI: 10.1001/archotol.1990.01870090039003

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

Review 1.  Tomotherapy for neurofibromatosis Type 2: case report and review of the literature.

Authors:  H-H Lee; S-L Lian; C-J Huang; M-Y Huang
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

2.  Residual and recurrent acoustic neuroma in hearing preservation procedures: neuroradiologic and surgical findings.

Authors:  A Mazzoni; V Calabrese; L Moschini
Journal:  Skull Base Surg       Date:  1996

Review 3.  Facial nerve neuroma. Report of two cases including histological and radiological imaging studies.

Authors:  G E Forton; L L Moeneclaey; F E Offeciers
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.